UNITED GUARDIAN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNITED GUARDIAN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $12.97M | Mar 22, 2018 |
| FY2016 | Dec 31, 2016 | $10.78M | Mar 23, 2017 |
| FY2015 | Dec 31, 2015 | $14.01M | Mar 24, 2016 |
| FY2014 | Dec 31, 2014 | $13.45M | Mar 26, 2015 |
| FY2013 | Dec 31, 2013 | $15.42M | Mar 24, 2014 |
| FY2012 | Dec 31, 2012 | $13.83M | Mar 21, 2013 |
| FY2011 | Dec 31, 2011 | $14.34M | Mar 26, 2012 |
| FY2011 | Dec 31, 2010 | $13.72M | Mar 26, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.25M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.58M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.57M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $4.66M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.30M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $4.76M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.35M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $3.84M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $2.58M | Mar 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.65M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.86M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $4.04M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $5.67M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.64M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $5.40M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $5.58M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $5.24M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $3.39M | Mar 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $463.6K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $456.8K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $464.0K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $490.8K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $478.6K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $451.2K | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $397.4K | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $399.5K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $646.1K | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $651.8K | Mar 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.47M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.14M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.53M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $5.31M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.59M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $4.48M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.95M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $3.99M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $2.29M | Mar 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $433.1K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $165.7K | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $75.2K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $116.4K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $43.4K | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $113.8K | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $75.0K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $38.1K | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $166.7K | Mar 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $13.80M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $12.92M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $10.64M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $12.24M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $11.92M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $12.36M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $12.54M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $12.85M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $14.87M | Mar 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.91M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.53M | Mar 21, 2025 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.23M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.88M | Mar 27, 2026 |
| FY2025 | Dec 31, 2023 | $11.39M | Mar 27, 2026 |
| FY2024 | Dec 31, 2022 | $9.27M | Mar 21, 2025 |
| FY2023 | Dec 31, 2021 | $9.82M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $10.35M | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | $10.63M | Mar 23, 2022 |
| FY2020 | Dec 31, 2018 | $10.92M | Mar 22, 2021 |
| FY2019 | Dec 31, 2017 | $11.40M | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $13.82M | Mar 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.77M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.42M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $10.93M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $8.81M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $9.36M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $9.89M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $10.17M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $10.47M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $10.47M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $13.19M | Mar 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.88M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $8.24M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | $830.5K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $531.2K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $591.4K | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.05M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $550.1K | Mar 26, 2020 |
| FY2019 | Dec 31, 2017 | $724.7K | Mar 26, 2020 |
| FY2018 | Dec 31, 2016 | $424.3K | Mar 21, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.59M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 4.59M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 4.59M | Mar 21, 2025 |
| FY2023 | Dec 31, 2022 | 4.59M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 4.59M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 4.59M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | 4.59M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | 4.59M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 4.59M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | 4.59M | Mar 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $459.4K | Mar 22, 2024 |
| FY2023 | Dec 31, 2022 | $3.12M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $5.19M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.58M | Mar 23, 2022 |
| FY2020 | Dec 31, 2019 | $5.05M | Mar 22, 2021 |
| FY2019 | Dec 31, 2018 | $4.82M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $6.51M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $3.44M | Mar 22, 2018 |
| FY2016 | Dec 31, 2015 | $4.59M | Mar 23, 2017 |
| FY2014 | Dec 31, 2014 | $3.68M | Mar 26, 2015 |